Obesity, estrogens and adipose tissue dysfunction – implications for pulmonary arterial hypertension

por Mair, Kirsty M., Gaw, Rosemary, MacLean, Margaret R.
Publicado 2020

Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension

por Mair, Kirsty M., Harvey, Katie Y., Henry, Alasdair D., Hillyard, Dianne Z., Nilsen, Margaret, MacLean, Margaret R.
Publicado 2019

Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females

por Dempsie, Yvonne, Nilsen, Margaret, White, Kevin, Mair, Kirsty M, Loughlin, Lynn, Ambartsumian, Noona, Rabinovitch, Marlene, MacLean, Margaret R
Publicado 2011

Serotonin Signaling Through the 5-HT(1B) Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension

por Hood, Katie Y., Mair, Kirsty M., Harvey, Adam P., Montezano, Augusto C., Touyz, Rhian M., MacLean, Margaret R.
Publicado 2017

Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension

por Dempsie, Yvonne, MacRitchie, Neil A., White, Kevin, Morecroft, Ian, Wright, Audrey F., Nilsen, Margaret, Loughlin, Lynn, Mair, Kirsty M., MacLean, Margaret R.
Publicado 2013